PMC:7358770 / 33305-33467
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1124 | 0-11 | Chemical | denotes | Carrageenan | MESH:D002351 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T371 | 99-106 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T495 | 0-11 | Chemical | denotes | Carrageenan | http://purl.obolibrary.org/obo/CHEBI_3435 |
T496 | 75-84 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T497 | 99-106 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32679328-20541583-48281346 | 157-160 | 20541583 | denotes | 118 |
T82869 | 157-160 | 20541583 | denotes | 118 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T206 | 0-162 | Sentence | denotes | Carrageenan and its structurally related compounds may serve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T953 | 0-11 | CHEBI:3435;CHEBI:3435 | denotes | Carrageenan |
T954 | 41-50 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T955 | 75-84 | CHEBI:60809;CHEBI:60809 | denotes | adjuvants |
T956 | 137-143 | UBERON:0002405 | denotes | immune |
T61413 | 1-15 | CHEBI:18154;CHEBI:18154 | denotes | arrageenan and |
T86563 | 16-25 | CHEBI:60809;CHEBI:60809 | denotes | its struc |
T50142 | 84-97 | NCBITaxon:11118 | denotes | for enhancin |
MyTest
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1124 | 0-11 | Chemical | denotes | Carrageenan | MESH:D002351 |